Hypoxia-related altitude illnesses

Journal of Travel Medicine

Volumn 20, Issue 4, 2013, Pages 247-255

  Netzer, Nikolaus ^a,b   Strohl, Kingman ^c,d   Faulhaber, Martin ^e   Gatterer, Hannes ^e   Burtscher, Martin ^e  

^a UNIVERSITY OF ULM   (Germany)

^b PARACELSUS MEDICAL UNIVERSITY   (Austria)

^c CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d LOUIS STOKES CLEVELAND VA MEDICAL CENTER   (United States)

^e UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; DEXAMETHASONE; GABAPENTIN; SALMETEROL; SUMATRIPTAN; TEMAZEPAM; THEOPHYLLINE;

ACCLIMATIZATION; ALTITUDE; ALTITUDE DISEASE; ANOREXIA; ATAXIA; BRAIN EDEMA; BREATHING; CALORIC INTAKE; CHEST TIGHTNESS; CLEARANCE; CONFUSION; COUGHING; DEHYDRATION; DIZZINESS; DROWSINESS; DYSPNEA; EXERCISE; FACE MASK; FATIGUE; FLUID INTAKE; FLUID RETENTION; GAS EXCHANGE; HALLUCINATION; HEADACHE; HEART OUTPUT; HUMAN; HYPERBARIC CHAMBER; HYPERVENTILATION; HYPOXEMIA; HYPOXIA; INFLAMMATION; INSOMNIA; INTRACRANIAL HYPERTENSION; LIQUID; LUNG EDEMA; LUNG VASOCONSTRICTION; OBESITY; OVEREXERTION; OXIDATIVE STRESS; OXYGEN DESATURATION; PHYSICAL ACTIVITY; PRESSURE; PREVALENCE; REVIEW; RISK FACTOR; SCORING SYSTEM; SLEEP; SLEEP DISORDER; SLEEP DISORDERED BREATHING; TACHYPNEA; VASODILATATION; VOMITING; WEAKNESS; WORKLOAD;

ACCLIMATIZATION; ALTITUDE SICKNESS; HUMANS; INCIDENCE; RISK FACTORS; TRAVEL;

EID: 84879794069     PISSN: 11951982     EISSN: 17088305     Source Type: Journal    
DOI: 10.1111/jtm.12017     Document Type: Review

References (89)

1. Burtscher M, Bachmann O, Hatzl T, et al. Cardiopulmonary and metabolic responses in healthy elderly during a one week hiking program at high-altitude. Eur J Appl Physiol 2001; 84: 379-386.
2. Hackett PH, Roach RC,. High altitude medicine. In:, Auerbach PS, ed. Wilderness medicine: management of wilderness and environmental emergencies. St. Louis: Mosby, 1995: 1-37.
3. Schoene RB,. Illnesses at high altitude. Chest 2008; 134: 402-416.
4. Basnyat B, Litch JA,. Medical problems of porters and trekkers in the Nepal Himalaya. Wilderness Environ Med 1997; 8: 78-81.
5. Basnyat B, Subedi D, Sleggs J, et al. Disoriented and ataxic pilgrims: an epidemiological study of acute mountain sickness and high-altitude cerebral edema at a sacred lake at 4300 m in the Nepal Himalayas. Wilderness Environ Med 2000; 11: 89-93.
6. Bärtsch P, Gibbs JS,. Effect of altitude on the heart and the lungs. Circulation 2007; 116: 2191-2202.
7. Wilson MH, Newman S, Imray CH,. The cerebral effects of ascent to high altitudes. Lancet Neurol 2009; 8: 175-191.
8. Boggild AK, Costiniuk C, Kain KC, Pandey P,. Environmental hazards in Nepal: altitude illness, environmental exposures, injuries, and bites in travelers and expatriates. J Travel Med 2007; 14: 361-368.
9. World Elevation Map. Homepage on the Internet. Available at: http://maps.howstuffworks.com/world-elevation-map.htm. (Accessed 2012 Sep 24).
10. Burgess KR, Johnson P, Edwards N, Cooper J,. Acute mountain sickness is associated with sleep desaturation at high altitude. Respirology 2004; 9: 485-492.
11. Hackett PH, Roach RC,. High-altitude illness. N Engl J Med 2001; 345: 107-114.
12. Scherrer U, Rexhaj E, Jayet PY, et al. New insights in the pathogenesis of high-altitude pulmonary edema. Prog Cardiovasc Dis 2010; 52: 485-492.
13. Weil JV,. Sleep at high altitude. High Alt Med Biol 2004; 5: 180-189.
14. Bloch KE, Latshang TD, Turk AJ, et al. Nocturnal periodic breathing during acclimatization at very high altitude at Mount Muztagh Ata (7,546 m). Am J Respir Crit Care Med 2010; 182: 562-568.
15. Nussbaumer-Ochsner Y, Ursprung J, Siebenmann C, et al. Effect of short-term acclimatization to high altitude on sleep and nocturnal breathing. Sleep 2012; 35: 419-423.
16. Burtscher M, Mairer K, Wille M, Broessner G,. Risk factors for high-altitude headache in mountaineers. Cephalalgia 2011; 31: 706-711.
17. Ward MP, Milledge JS, West JB,. High altitude medicine and physiology. London: Arnold, 2000.
18. Roach RC, Bärtsch P, Hackett PH, Oelz O, The Lake Louise AMS Scoring Consensus Committee. The Lake Louise acute mountain sickness scoring system. In:, Sutton JR, Houston CS, Coates G, eds. Hypoxia and molecular medicine. Burlington, VT: Queens City Press, 1993: 272-274.
19. Erba P, Anastasi S, Senn O, et al. Acute mountain sickness is related to nocturnal hypoxemia but not to hypoventilation. Eur Respir J 2004; 24: 303-308.
20. Netzer NC, Strohl KP,. Sleep and breathing in recreational climbers at an altitude of 4200 and 6400 meters: observational study of sleep and patterning of respiration during sleep in a group of recreational climbers. Sleep Breath 1999; 3: 75-82.
21. Thomassen O, Skaiaa SC,. High-altitude cerebral edema with absence of headache. Wilderness Environ Med 2007; 18: 45-47.
22. Johnson BG, Wright AD, Beazley MF, et al. The sharpened Romberg test for assessing ataxia in mild acute mountain sickness. Wilderness Environ Med 2005; 16: 62-66.
23. Bärtsch P, Maggiorini M, Ritter M, et al. Prevention of high-altitude pulmonary edema by nifedipine. N Engl J Med 1991; 325: 1284-1289.
24. Mairer K, Wille M, Bucher T, Burtscher M,. Prevalence of acute mountain sickness in the Eastern Alps. High Alt Med Biol 2009; 10: 239-245.
25. Wu TY, Ding SQ, Liu JL, et al. Who should not go high: chronic disease and work at altitude during construction of the Qinghai-Tibet railroad. High Alt Med Biol 2007; 8: 88-107.
26. Gabry AL, Ledoux X, Mozziconacci M, Martin C,. High-altitude pulmonary edema at moderate altitude (<2,400 m; 7,870 feet): a series of 52 patients. Chest 2003; 123: 49-53.
27. Hackett PH, Rennie D, Levine HD,. The incidence, importance, and prophylaxis of acute mountain sickness. Lancet 1976; 27: 1149-1155.
28. Menon ND,. High-altitude pulmonary edema: a clinical study. N Engl J Med 1965; 273: 66-73.
29. Richalet JP, Larmignat P, Poitrine E, et al. Physiological risk factors for severe high-altitude illness: a prospective cohort study. Am J Respir Crit Care Med 2012; 185: 192-198.
30. Basnyat B, Murdoch DR,. High-altitude illness. Lancet 2003; 361: 1967-1974.
31. Schneider M, Bernasch D, Weymann J, et al. Acute mountain sickness: influence of susceptibility, preexposure, and ascent rate. Med Sci Sports Exerc 2002; 34: 1886-1891.
32. Roach RC, Maes D, Sandoval D, et al. Exercise exacerbates acute mountain sickness at simulated high altitude. J Appl Physiol 2000; 88: 581-585.
33. Ri-Li G, Chase PJ, Witkowski S, et al. Obesity: associations with acute mountain sickness. Ann Intern Med 2003; 139: 253-257.
34. Wu TY, Ding SQ, Liu JL, et al. Smoking, acute mountain sickness and altitude acclimatisation: a cohort study. Thorax 2012; 67: 914-919.
35. Mieske K, Flaherty G, O'Brien T,. Journeys to high altitude-risks and recommendations for travelers with preexisting medical conditions. J Travel Med 2010; 17: 48-62.
36. Küpper T, Schöffl V, Netzer N,. Cheyne stokes breathing at high altitude: a helpful response or a troublemaker? Sleep Breath 2008; 12: 123-127.
37. Palmer BF,. Physiology and pathophysiology with ascent to altitude. Am J Med Sci 2010; 340: 69-77.
38. Allemann Y, Hutter D, Lipp E, et al. Patent foramen ovale and high-altitude pulmonary edema. JAMA 2006; 296: 2954-2958.
39. Bloch KE, Turk AJ, Maggiorini M, et al. Effect of ascent protocol on acute mountain sickness and success at Muztagh Ata, 7546 m. High Alt Med Biol 2009; 10: 25-32.
40. Pollard AJ,. Altitude induced illness. BMJ 1992; 304: 1324-1325.
41. Bärtsch P, Bailey DM, Berger MM, et al. Acute mountain sickness: controversies and advances. High Alt Med Biol 2004; 5: 110-124.
42. Luks AM,. Clinician's corner: what do we know about safe ascent rates at high altitude? High Alt Med Biol 2012; 13: 147-152.
43. Richardson A, Watt P, Maxwell N,. The effect of hypohydration severity on the physiological, psychological and renal hormonal responses to hypoxic exercise. Eur J Appl Physiol 2009; 106: 123-130.
44. Castellani JW, Muza SR, Cheuvront SN, et al. Effect of hypohydration and altitude exposure on aerobic exercise performance and acute mountain sickness. J Appl Physiol 2010; 109: 1792-1800.
45. Richardson A, Watt P, Maxwell N,. Hydration and the physiological responses to acute normobaric hypoxia. Wilderness Environ Med 2009; 20: 212-220.
46. Dehnert C, Böhm A, Menold E, et al. Simulated altitude during the night reduces severity of acute mountain sickness. Med Sci Sports Exerc 2009; 41: 175.
47. Beidleman BA, Muza SR, Fulco CS, et al. Intermittent altitude exposures reduce acute mountain sickness at 4300 m. Clin Sci 2004; 106: 321-328.
48. Burtscher M, Brandstätter E, Gatterer H,. Preacclimatization in simulated altitudes. Sleep Breath 2008; 12: 109-114.
49. Luks AM,. Can patients with pulmonary hypertension travel to high altitude? High Alt Med Biol 2009; 10: 215-219.
50. Schoonman GG, Sándor PS, Agosti RM, et al. Normobaric hypoxia and nitroglycerin as trigger factors for migraine. Cephalalgia 2006; 26: 816-819.
51. Luks AM, McIntosh SE, Grissom CK, et al. Wilderness Medical Society consensus guidelines for the prevention and treatment of acute altitude illness. Wilderness Environ Med 2010; 21: 146-155.
52. Küpper T, Milledge JS, Hillebrandt D, et al. Work in hypoxic conditions-consensus statement of the Medical Commission of the Union Internationale des Associations d'Alpinisme (UIAA MedCom). Ann Occup Hyg 2011; 55: 369-386.
53. Burtscher M,. Effects of acute altitude exposure: which altitude can be tolerated? Wien Med Wochenschr 2010; 160: 362-371.
54. 2 values during short-term exposure to hypoxia. High Alt Med Biol 2004; 5: 335-340.
55. Nickol AH, Leverment J, Richards P, et al. Temazepam at high altitude reduces periodic breathing without impairing next-day performance: a randomized cross-over double-blind study. J Sleep Res 2006; 15: 445-454.
56. Luks AM,. Which medications are safe and effective for improving sleep at high altitude? High Alt Med Biol 2008; 9: 195-198.
57. Windsor JS, Rodway GW,. Sleep disturbance at altitude. Curr Opin Pulm Med 2012; 18: 554-560.
58. Burtscher M, Likar R, Nachbauer W, Philadelphy M,. Aspirin for prophylaxis against headache at high altitudes: randomised, double blind, placebo controlled trial. BMJ 1998; 316: 1057-1058.
59. Burtscher M, Likar R, Nachbauer W, et al. Effects of aspirin during exercise on the incidence of high-altitude headache: a randomized, double-blind, placebo-controlled trial. Headache 2001; 41: 542-545.
60. Lipman GS, Kanaan NC, Holck PS, et al. Ibuprofen prevents altitude illness: a randomized controlled trial for prevention of altitude illness with nonsteroidal anti-inflammatories. Ann Emerg Med 2012; 59: 484-490.
61. High altitude sickness. Med Lett Drugs Ther 1992; 34: 84-86.
62. Basnyat B, Gertsch JH, Holck PS, et al. Acetazolamide 125 mg BD is not significantly different from 375 mg BD in the prevention of acute mountain sickness: the prophylactic acetazolamide dosage comparison for efficacy (PACE) trial. High Alt Med Biol 2006; 7: 17-27.
63. Basnyat B, Gertsch JH, Johnson EW, et al. Efficacy of low-dose acetazolamide (125 mg BID) for the prophylaxis of acute mountain sickness: a prospective, double-blind, randomized, placebo-controlled trial. High Alt Med Biol 2003; 4: 45-52.
64. Ritchie N, Baggott A, Todd A,. Acetazolamide for the prevention of acute mountain sickness-a systematic review and meta-analysis. J Travel Med 2012; 19: 298-307.
65. Leshem E, Caine Y, Rosenberg E, et al. Tadalafil and acetazolamide versus acetazolamide for the prevention of severe high altitude illness. J Travel Med 2012; 19: 308-310.
66. Basnyat B,. Acclimatizing with acetazolamide. J Travel Med 2012; 19: 281-283.
67. Küpper TE, Strohl KP, Hoefer M, et al. Low-dose theophylline reduces symptoms of acute mountain sickness. J Travel Med 2008; 15: 307-314.
68. Fischer R, Lang SM, Steiner U, et al. Theophylline improves acute mountain sickness. Eur Respir J 2000; 15: 123-127.
69. Johnson TS, Rock PB, Fulco CS, et al. Prevention of acute mountain sickness by dexamethasone. N Engl J Med 1984; 310: 683-686.
70. Schoene RB,. Dexamethasone: by safe means, by fair means. High Alt Med Biol 2005; 6: 273-275.
71. Maggiorini M, Brunner-La Rocca HP, Peth S, et al. Both tadalafil and dexamethasone may reduce the incidence of high-altitude pulmonary edema: a randomized trial. Ann Intern Med 2006; 145: 497-506.
72. Sartori C, Duplain H, Lepori M, et al. High altitude impairs nasal transepithelial sodium transport in HAPE-prone subjects. Eur Respir J 2004; 23: 916-920.
73. Grissom CK, Roach RC, Sarnquist FH, Hackett PH,. Acetazolamide in the treatment of acute mountain sickness: clinical efficacy and effect on gas exchange. Ann Intern Med 1992; 116: 461-465.
74. Burtscher M, Likar R, Nachbauer W, et al. Ibuprofen versus sumatriptan for high-altitude headache. Lancet 1995; 346: 254-255.
75. Harris NS, Wenzel RP, Thomas SH,. High altitude headache: efficacy of acetaminophen vs. ibuprofen in a randomized, controlled trial. J Emerg Med 2003; 24: 383-387.
76. Ferrazzini G, Maggiorini M, Kriemler S, et al. Successful treatment of acute mountain sickness with dexamethasone. BMJ 1987; 294: 1380-1382.
77. Oelz O, Maggiorini M, Ritter M, et al. Nifedipine for high altitude pulmonary oedema. Lancet 1989; 25: 1241-1244.
78. Wu T, Liu J,. Alcohol and aspirin in combination with dexamethasone causes gastrointestinal bleeding at high altitude. Wilderness Environ Med 2006; 17: 69-71.
79. McMurdo ME, Hutchison GL, Lindsay G,. Taste disturbance with acetazolamide. Lancet 1990; 336: 1190-1191.
80. Kelly TE, Hackett PH,. Acetazolamide and sulfonamide allergy: a not so simple story. High Alt Med Biol 2010; 11: 319-323.
81. Yoshioka M, Ohnishi N, Koishi T, et al. Studies on interactions between functional foods or dietary supplements and medicines: IV. Effects of ginkgo biloba leaf extract on the pharmacokinetics and pharmacodynamics of nifedipine in healthy volunteers. Biol Pharm Bull 2004; 27: 2006-2009.
82. Luks AM, Swenson ER,. Medication and dosage considerations in the prophylaxis and treatment of high-altitude illness. Chest 2008; 133: 744-755.
83. Gertsch JH, Basnyat B, Johnson EW, et al. Randomised, double blind, placebo controlled comparison of ginkgo biloba and acetazolamide for prevention of acute mountain sickness among Himalayan trekkers: the prevention of high altitude illness trial (PHAIT). BMJ 2004; 328: 797.
84. Jafarian S, Gorouhi F, Salimi S, Lotfi J,. Sumatriptan for prevention of acute mountain sickness: randomized clinical trial. Ann Neurol 2007; 62: 273-277.
85. Jafarian S, Abolfazli R, Gorouhi F, et al. Gabapentin for prevention of hypobaric hypoxia-induced headache: randomized double-blind clinical trial. J Neurol Neurosurg Psychiatry 2008; 79: 321-323.
86. Seupaul RA, Welch JL, Malka ST, Emmett TW,. Pharmacologic prophylaxis for acute mountain sickness: a systematic shortcut review. Ann Emerg Med 2012; 59: 307-317.
87. Bärtsch P, Roach R,. Acute mountain sickness and high-altitude cerebral edema. In:, Hornbein TF, Schoene RB, eds. High altitude. An exploration of human adaptation. New York: Marcel Dekker, 2001: 731-776.
88. Shimada H, Morita T, Kunimoto F, Saito S,. Immediate application of hyperbaric oxygen therapy using a newly devised transportable chamber. Am J Emerg Med 1996; 14: 412-415.
89. Koch RO, Hinterhuber L, Faulhaber M, et al. A successful therapy of high-altitude pulmonary edema with a CPAP helmet on Lenin Peak. Clin J Sport Med 2009; 19: 72-73.